About us
Since our inception in 2017, Medigrowth’s mission has been to alleviate symptoms of a wide range of illnesses that drastically impact quality of life. For patients with unmet needs, alternative therapies may offer therapeutic benefits for certain medical conditions and treatment side effects.
Medigrowth Australia distributes pharmaceutical grade, Australian made AU GMP and GMP products sourced from trusted overseas supply partners. Australian-owned and operated, Medigrowth is fully licensed by the federal Office of Drug Control for cultivation, manufacturing and research.
‘We are committed to advancing real world data and clinical trial initiatives in plant based therapies. we share a combined vision for creating a company with the ability to effect substantial positive change in patient wellbeing.’
ADAM GUSKICH AND TODD McCLELLAN, MEDIGROWTH FOUNDERS